跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KRABEVA 100 per 4 ml - SFDA Drug Approval Details
Approvals
/
SFDA
/
KRABEVA 100 per 4 ml
Authorized
BIOLOGICAL
KRABEVA 100 per 4 ml
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
29058466331783e2
Company
Unknown
Type
Biological
Approval Details
Approval Id
29058466331783e2
Drug Approval Sfda Name
KRABEVA 100 per 4 ml
Trade Name
KRABEVA 100 per 4 ml
Generic Name
Bevacizumab
Register Number
0905245272
Register Year
2024
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
4
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000000146-25-100000073871
Price
698.45
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
29058466331783e2
Type
Biological
Back to SFDA Approvals